| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
University of Virginia Health System, Department of Pediatrics, Division of Endocrinology (J.N.R., P.A.C., A.D.R.); Department of Medicine and University of Virginia Department of Human Services (A.W.); and Department of Pharmacology (A.D.R.), Charlottesville, Virginia 22908; Department of Medicine (C.S.M.), Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215; and Department of Pediatrics (C.M.G.), School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14214
Address all correspondence and requests for reprints to: James N. Roemmich, M.D., Ph.D., Department of Pediatrics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Farber Hall, Room G56, 3435 Main Street, Building 26, Buffalo, New York 14214-3000. E-mail: roemmich{at}buffalo.edu.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Human studies have shown that serum leptin concentrations and bone mass are directly related (15, 19, 20). Evidence for a stimulatory role of leptin on bone mineralization in humans includes direct relationships between serum leptin concentrations and bone mineral mass and BMD in lean women (19) and lean girls (20). However, all have shown rather weak associations and suffer from incomplete control for potential confounding factors such as prevailing serum hormone concentrations.
Puberty is a critical time for maximizing bone mineral and thereby delaying or preventing later osteoporosis. Peak bone mass is attained by the end of second decade, and bone accrual is maximal during midpuberty, which coincides with rising sex steroid secretion and peak GH-IGF-I secretion. Both estradiol and the GH-IGF-I axis stimulate bone mineral accrual (21, 22, 23, 24). Only two studies have investigated the relationship of fasting serum leptin concentrations with bone mineral in youth. These studies (15, 20) did not include boys and did not adjust for the potential confounding effects of estradiol or the GH-IGF-I axis on bone. The purpose of the present investigation was to determine whether serum leptin concentrations are independently related to BMC, BMD, and bone mineral apparent density (BMAD) after statistical correction for chronological age, fat mass (FM), bone-free fat-free mass (FFM), and serum estradiol and IGF-I concentrations in healthy, normal weight, prepubertal, and pubertal boys and girls.
| Subjects and Methods |
|---|
|
|
|---|
Boys (n = 28) and girls (n = 31) enrolled in a longitudinal study of the endocrine control of growth, maturation, and body composition were evaluated. Entrance and continued participation in the study required normal growth, including a height, height velocity, and weight within two SDs of the mean for chronological age. Stage of secondary sex characteristics was assessed by the method of Tanner (25) by an experienced pediatric endocrinologist. The study was reviewed and approved by the University of Virginia Human Investigation Committee. Informed consent was obtained from a parent and assent from each child. The present study provides a cross-sectional analysis of the bone mineral, body composition, and serum leptin, IGF-I, and estradiol concentrations of these youth.
Bone mineral/regional body composition
BMC, BMD, and BMAD of the whole body, femoral neck, midradius, and lumbar spine 24 were measured by dual-energy x-ray absorptiometry (DEXA; QDR 2000, Hologic, Inc., Waltham, MA). Transverse scans were made with a pencil beam from head to toe at 1-cm intervals. All scans were analyzed with Hologic enhanced whole body software (version 5.64) by the same technician. BMADs of the whole body and specific regions were calculated as described by Katzman et al. (26). Total BMC data were also presented as BMC/height, because of uncertainty of the accuracy of the total body reference volume prediction equation of Katzman et al. (26).
Body composition
Body composition was estimated by a four-compartment model (27). Body density was measured by underwater weighing. Residual volume was measured, on land, by nitrogen washout, with the subject seated in the same position as that used during the underwater weighing. Total body water was measured by deuterium dilution (27). Measurement of BMC was made by DEXA using a QDR 2000 bone densitometer (Hologic, Inc.). The four-compartment model of Lohman (28) was used to estimate the percentage body fat, FM, and FFM. The validation of the use of this model in our laboratory has been reported (27). BMC was subtracted from the four-compartment FFM, for a measure of bone-free lean tissue mass, which was then used in the hierarchical regression analyses.
Anthropometry
All height measures were completed by a trained anthropometrist (J.N.R.) as recommended (29).
Assays
Blood for hormone analyses was withdrawn at 0600 h after, an overnight stay, at the University of Virginia General Clinical Research Center. Starting with breakfast the previous day, the subjects consumed meals and snack constant for energy, fat (30% of calories), protein (15% of calories), and carbohydrate (55% of calories) at standard times. Serum leptin concentration was measured by RIA as previously described (14). The sensitivity of the leptin assay is 31 pM, with an intraassay coefficient of variation (CV) of 8.33.4% and interassay CV of 6.23.0% within the range of 306-1600 pM. IGF-I concentrations were measured by RIA (Nichols Institute Diagnostics, San Juan Capistrano, CA). IGF-I concentrations were measured after acid-ethanol extraction and had intraassay CV of 2.4% and 3.0% at 0.07 nM and 0.12 nM and interassay CV of 5.2% and 8.4% at 0.07 nM and 0.11 nM, respectively. The sensitivity was 0.01 nM. Serum estradiol concentration was measured by RIA, using kits from Diagnostic Products (Los Angeles, CA). The sensitivity of the estradiol assay was 36.7 pM, with an intraassay CV of 47% within the range of 183.64038.1 pM. The interassay CV ranged from 4.28.1% within the range of 183.63762.8 pM. Estradiol concentrations were not considered in relation to ovarian cycles.
Statistics
Two-way [sex (boys vs. girls) x maturation (prepubertal vs. pubertal)] ANOVA was used to test for group differences in total and regional BMC, BMD, and BMAD as well as body composition and serum hormone concentrations. Pearson correlations were used to examine the strength of the relationship between physical characteristics, serum hormone concentrations, and bone mineralization variables. Hierarchical regression was used to determine whether serum log(10) leptin concentrations were related to total and regional BMC, BMD, and BMAD after initial adjustment for a block of variables pertaining to body size (chronological age, FM, bone-free FFM) and then for a block of variables pertaining to serum IGF-I and estradiol concentrations. Thus, a series of three blocks was used in the hierarchical regression: block 1 (chronological age, FM, bone-free FFM), block 2 (serum IGF-I and estradiol concentrations), and block 3 (serum log(10) leptin concentrations). The predictors in block 2 were added to those of block 1 and that of block 3 added to blocks 1 and 2. The increase in R2 between consecutive blocks corresponds to the proportion of variance of the dependent variable that is shared by the newly added variable(s). The order of the blocks determines the variables that are being controlled. The effects of variables entered in earlier steps are partialed from relationships in later steps (30). The leptin concentrations were log transformed because the absolute values were not normally distributed.
| Results |
|---|
|
|
|---|
|
|
|
0.001), BMD (P
0.001), and BMC/height (P
0.001); midradius BMC (P = 0.003), BMD (P = 0.003), and BMAD (P = 0.04); and lumbar spine BMC (P
0.001), BMD (P
0.001), and BMAD (P = 0.006). After accounting for physical characteristics and serum IGF-I and sex steroid concentrations, serum log(10) leptin concentrations did not significantly increase R2 (see columns 5 and 6 of Table 4
|
| Discussion |
|---|
|
|
|---|
In the first block of the hierarchical regression model, bone mineralization data were adjusted for chronological age, FM, and bone-free FFM, because increases in bone mineral during childhood and adolescence are a reflection of increases in body size and body weight (26, 31). Body weight and its fat and fat-free subcomponents are directly related to the amount of bone mineral in youth (26) and adults (3). Body weight increases bone mineralization by increasing the mechanical loading on the bone (7). Bone-free FFM includes the skeletal muscles, which also exert mechanical (pulling) forces on bone when producing body movements or stabilizing forces. Adjusting for FM, which was measured very accurately in the present study, creates a very stringent test for the independent relationship of leptin with bone mineralization; because we have shown that, in these same subjects, leptin is secreted in direct proportion to the amount of FM (1). The high correlation between serum leptin concentrations and FM suggests that they convey similar information. Others have reported a direct relationship of FM with bone mineral and have hypothesized that additional FM acts as a mechanical stimulus for bone mineralization (3, 4, 5). Thus, a relationship between serum leptin concentrations and bone mineral could actually reflect the relationship of FM and bone mineral because of the collinearity of leptin and FM with bone mineral measures. The inclusion of FM in the first block of the model accounts for the variance contributed by leptin regarding body adiposity, so that any relationship between leptin and bone mineral is independent of the collinearity of leptin and FM. In the second block of the hierarchical regression, bone mineralization data were further adjusted for serum IGF-I and estradiol concentrations. IGF-I serves as a marker of the integrated GH-IGF-I axis, and both GH (21) and IGF-I (22) increase bone mineral, as does estradiol (23, 24). These hormonal variables increased R2 for BMC, BMD, and BMAD variables beyond that of the physical characteristics (Table 4
). After statistically adjusting for all five of these factors, the serum leptin concentration was not related to total body or regional bone mineral (Table 4
).
Previous investigations of children (32) and adults (22, 33, 34) have also reported no independent effect of leptin on bone mineral or markers of bone metabolism (33, 34). However, others have reported that the relationship between bone mineralization and serum leptin concentrations is significant and positive but low in magnitude (19, 35, 36), including studies of children (15, 20), but these studies did not statistically adjust for confounding correlated variables that also influence bone mineral, such as FM or serum estradiol and IGF-I concentrations. The importance of including FM in the model, because of the collinearity of leptin and FM with bone mineral measures, is discussed above.
The role of leptin on bone mineral of humans remains unclear. Though the results of the present study imply that leptin does not increase bone mineral of youth beyond the biomechanical influence of body weight and physiological influences of FM, sex steroids, and the GH-IGF-I axis, previous research suggests that leptin does play some function in bone physiology. For instance, leptin exerts a dosedependent increase in osteoblast differentiation and decrease in adipocyte differentiation in a bipotential human marrow stromal cell line (37). Leptin seems to have a more robust effect on bone mineral in ob/ob mice (16, 17, 18). However, data from ob/ob mice may not be applicable to human bone physiology, because the greater bone mass observed in ob/ob mice has not been observed in a man who does not produce leptin and is osteopenic, or in leptin-deficient women who have normal bone mass (38).
In conclusion, we have shown that, in boys and girls, serum leptin concentrations are not related to bone mineral independent of chronological age, FM, bone-free FFM, and serum IGF-I and estradiol concentrations and support neither the stimulatory (16) nor the inhibitory (17, 18) hypotheses of leptin on bone mineral. Our correlational study cannot prove or disprove a causal relationship between leptin and bone mineral. Future research should determine whether leptin indeed has a stimulatory influence on bone formation or whether the inhibitory hypothesis is valid. Furthermore, because of the potential importance of sex steroids and the GH-IGF-I axis on modifying the effect of leptin on bone mineral, research should determine whether the physiologic role of leptin on bone is similar in children, adolescents, and adults.
| Acknowledgments |
|---|
| Footnotes |
|---|
Present address for P.A.C.: Department of Pediatrics, University of Louisville, 571 South Floyd Street, Suite 314, Louisville, Kentucky 40202.
Abbreviations: BMAD, Bone mineral apparent density; BMC, bone mineral content; BMD, bone mineral density; CV, coefficient(s) of variation; DEXA, dual-energy x-ray absorptiometry; FFM, fat-free mass; FM, fat mass.
Received December 18, 2001.
Accepted October 23, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. A Venner, P. K Doyle-Baker, M. E Lyon, and T. S Fung A meta-analysis of leptin reference ranges in the healthy paediatric prepubertal population Ann Clin Biochem, January 1, 2009; 46(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Misra, R. Prabhakaran, K. K. Miller, M. A. Goldstein, D. Mickley, L. Clauss, P. Lockhart, J. Cord, D. B. Herzog, D. K. Katzman, et al. Prognostic Indicators of Changes in Bone Density Measures in Adolescent Girls with Anorexia Nervosa-II J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1292 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Crabbe, S. Goemaere, H. Zmierczak, I. Van Pottelbergh, D. De Bacquer, and J.-M. Kaufman Are serum leptin and the Gln223Arg polymorphism of the leptin receptor determinants of bone homeostasis in elderly men? Eur. J. Endocrinol., May 1, 2006; 154(5): 707 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P Garnett, W. Hogler, B. Blades, L. A Baur, J. Peat, J. Lee, and C. T Cowell Relation between hormones and body composition, including bone, in prepubertal children Am. J. Clinical Nutrition, October 1, 2004; 80(4): 966 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wilson, J. Fisher, K. Chikazawa, R. Yoda, A. Legendre, D. Mook, and K. G. Gould Leptin Administration Increases Nocturnal Concentrations of Luteinizing Hormone and Growth Hormone in Juvenile Female Rhesus Monkeys J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4874 - 4883. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Parfitt What Is Bone Mineralization? J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 5043 - 5043. [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |